Glycomine is a Biotech company based in San Carlos, CA. It has raised $45M in total funding. Latest round: Series B.
Glycomine funding overview
Glycomine is a Biotech company based in San Carlos, CA. Glycomine has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2019. The round record for Glycomine runs through 2019; nothing later has been disclosed. Investors on record include Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures. 5 distinct backers are named across the disclosed rounds.
Glycomine at a glance
Total raised
$45M
Latest round
Series B
Latest round date
August 2019
Industry
Biotech
Headquarters
San Carlos, CA
Notable investors
Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures
Frequently asked about Glycomine funding
How much has Glycomine raised?
Glycomine has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Glycomine?
Novo Holdings A/S, Asahi Kasei Pharma Corporation, Mission Bay Capital, Sanderling, Chiesi Ventures are named among the investors backing Glycomine.
What was the latest Glycomine funding round?
The most recent disclosed round is a Series B, announced in August 2019.
Where is Glycomine based?
Glycomine is based in San Carlos, CA.
What sector does Glycomine operate in?
Glycomine is tracked under Biotech from San Carlos, CA, with $45M in disclosed funding.
When did Glycomine last raise?
The last disclosed Glycomine round closed in August 2019 at Series B.
Round data for Glycomine is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Carlos and backer lists below.
